Skip to content

Vascular Biogenics reiterated as buy by Wainwright

April 21, 2017

Vascular Biogenics Ltd (NASDAQ:VBLT)‘s stock had its “buy” rating reaffirmed by stock analysts at HC Wainwright in a report issued on Tuesday. They presently have a $11.00 price target on the biopharmaceutical company’s stock. HC Wainwright’s target price would indicate a potential upside of 113.59% from the company’s previous close.

http://bit.ly/2pYg5aU

Advertisements

From → Uncategorized

Leave a Comment

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: